Somatic mosaic chromosomal alterations and death of cardiovascular disease causes among cancer survivors: an analysis of the UK Biobank
Sun, M.; Cyr, M.-C.; Sandoval, J.; Lemieux-Perreault, L.-P.; Busque, L.; Tardif, J.-C.; Dube, M.-P.
Show abstract
Cancer survivors are at an increased risk of cardiovascular disease (CVD) compared to the general population. Here, we evaluated the impact of somatic mosaic chromosomal alterations (mCAs) on death of CVD causes, coronary artery disease (CAD) causes, from cancer, and of any cause in patients with a cancer diagnosis within the UK Biobank (n=48 919). mCAs were derived from DNA genotyping array intensity data and long-range chromosomal phase inference from participants. Overall, 10 070 individuals (20.6%) carried [≥]1 mCA clone. In adjusted analyses, mCA was associated with an increased risk of death of CAD causes (hazard ratio [HR]: 1.37, 95% confidence interval [CI]: 1.09-1.71, P=0.006), from cancer (HR: 1.06, 95% CI: 1.00-1.11, P=0.041), and death of any cause (HR: 1.07, 95% CI: 1.02-1.12, P=0.005). Among cancer survivors, carriers of any mCA are at an increased risk of death of CAD causes and of any cause as compared to non-carriers.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cancer and the risk of COVID-19 diagnosis, hospitalisation, and death: a population-based multi-state cohort study including 4,618,377 adults in Catalonia, Spain 94%
- Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomization study 93%
- Methylation scores for smoking, alcohol consumption, and body mass index and risk of seven types of cancer 93%
Similar papers in this journal
- Identifying therapeutic targets for cancer: 2,094 circulating proteins and risk of nine cancers 94%
- Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction 94%
- A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk 93%
Similar papers in this journal
- Repurposing cardiovascular disease prediction models for cancer 92%
- Germline Allelic Expression of Genes at 17q22 Locus Associates with Risk of Breast Cancer 90%
- PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from All of Us cohort 90%
Similar papers in this journal
- A comprehensive systematic review and meta-analysis of the global data involving 61,532 cancer patients with SARS-CoV-2 infection 92%
- The tumor burden of metastatic colorectal cancer patients at initial diagnosis, pre- versus post-Covid-19 lockdown 92%
- Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study 89%
Similar papers in this journal
- COVID-19 Outcomes in Patients with Cancer: Findings from the University of California Health System Database 90%
- Associations of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) Cancer Prevention Recommendations with Stages of Colorectal Carcinogenesis 90%
- Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.